West Pharmaceutical Services Inc (BSP:W2ST34)
R$ 55.16 0.16 (0.29%) Market Cap: 139.83 Bil Enterprise Value: 138.71 Bil PE Ratio: 48.32 PB Ratio: 8.58 GF Score: 91/100

West Pharmaceutical Services Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 04:15PM GMT
Release Date Price: R$74.9
Casey Rene Woodring
JPMorgan Chase & Co, Research Division - Research Analyst

My name is Casey Woodring in the Life Science, Tools Equity Research team here at JPMorgan. Welcome to our Annual Healthcare Conference. I'm pleased to introduce our next company, West Pharmaceuticals. Just a quick reminder for those listening before I hand it off to the management team here. If you'd like to ask a question during the Q&A portion of the presentation, there's an option to do so on the website. With that, I'll turn it over to Eric. Eric?

Eric M. Green
West Pharmaceutical Services, Inc. - President, CEO & Director

Great. Thank you, Casey, and thank you and JPMorgan for inviting us to this conference. Wish we were in person but in today's environment this surprise is a best alternative. I also want to welcome all the attendees to this presentation. Really thankful that you are part of today's call, and hopefully, we give more insights on who we are at West.

To Slide 2, if you just hopefully have access to the slides, I'd just remind everyone around

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot